Tachon’s syndrome (suracute back and/or thoracic pain following local injections of corticosteroids). A report of 318 French cases

• Published in: Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2005, Vol.72 (1), p.66-68
• Main Authors: Berthelot, Jean-Marie, Tortellier, Laetitia, Guillot, Pascale, Prost, Alain, Caumon, Jean-Pierre, Glemarec, Joëlle, Maugars, Yves
• Format: Article
• Language: English
• Subjects: Adrenal Cortex Hormones - administration & dosage; Adrenal Cortex Hormones - adverse effects; Back pain; Back Pain - chemically induced; Chest Pain - chemically induced; Corticosteroid; Female; France; Humans; Injections; Injections, Epidural; Injections, Intralesional; Male; Nicolau; Rheumatic Diseases - drug therapy; Side-effects; Surveys and Questionnaires; Toxicity; Urticaria - chemically induced
• ISSN: 1297-319X
• DOI: 10.1016/j.jbspin.2004.01.005

Objectives. – To assess the frequency, features, and outcome of excruciating lumbar, dorsal, and/or thoracic pain following injections of local corticosteroids in rare instances. Methods. – A questionnaire mailed to 500 French rheumatologists. Results. – Three hundred and eighteen cases were reported by 92 rheumatologists (one event per 8000 injections or 6.5 years of practice), following injections into lumbar epidural space (39%), an upper limb (30%), a lower limb (mostly the heel) (24%), or other locations (7%), of cortivazol (67%), hydrocortisone (25%), betamethasone (7%), or paramethasone (1%). Symptoms occurred 1–5 min (78%) or less than 1 min (22%) after injection, and highly acute axial pain usually lasted for less than 5 min (34%) or 5–15 min (51%). In addition to pain in lumbar (84%) and/or dorsal regions (25%) [often preceded or associated with thoracic pain (36%)], other signs were: anxiety (87%), shortness of breath (64%), facial flushing (64%), diffuse sweating (41%), agitation (29%), transient cough (23%), abdominal pain (20%), transient hypertension (15%), paleness (10%), hypotension (8%), diarrhoea (3%) and headache (3%). None of these patients was known to be allergic, and urticaria developed in only 2%. Outcome was favourable in all cases (even though 4/318 patients were transiently hospitalised) with an overall duration of 25 ± 71 min. Another injection was performed later in 146/318 cases (46%), but Tachon’s syndrome recurred in only 20 of these 146 patients (14%). Conclusion. – The outcome of this impressive syndrome seems excellent. Tachon’s syndrome might be the venous counterpart of Nicolau’s syndrome (injection of corticosteroids in an artery).